Curefit Bolsters Board for IPO Push

### Strategic Board Enhancement Signals IPO Readiness
Curefit Healthcare, the parent entity of the popular fitness platform Cult.fit, has strategically bolstered its board with the appointment of four independent directors. This significant governance enhancement includes Kalpana Morparia, former Chairman of JPMorgan South and Southeast Asia; Arun M. Kumar, Managing Partner at Celesta Capital and former KPMG India Chairman; Dr. Indu Bhushan, the founding CEO of Ayushman Bharat-PMJAY; and Pragya Misra, Head of Strategy & Global Affairs, India at OpenAI. These appointments underscore the company's proactive approach to strengthening its oversight, particularly as it intensifies preparations for a potential initial public offering (IPO). The move follows closely on the heels of a ₹440 crore ($47 million) funding infusion from Temasek in March 2026, further signaling its trajectory toward public markets. With bankers reportedly lined up for a proposed ₹2,500 crore IPO, these seasoned professionals are expected to lend critical expertise in finance, global consulting, healthcare policy, and technology to guide Curefit through its next growth phase and potential market debut.